Cognition Therapeutics Stock (NASDAQ: CGTX) stock price, news, charts, stock research, profile.
Open | $0.55 |
Close | - |
Volume / Avg. | 297.20K / 976.95K |
Day Range | $0.52 - $0.55 |
52 Wk Range | 0.54 - 2.95 |
Market Cap | $21.97M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 3.3% |
Days to Cover | 1.53 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cognition Therapeutics (NASDAQ:CGTX) through any online brokerage.
Other companies in Cognition Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Ocuphire Pharma (NASDAQ:OCUP).
Cognition Therapeutics has a consensus price target of $7.67.
The stock price for Cognition Therapeutics (NASDAQ: CGTX) is $0.5241 last updated September 23, 2024 at 12:27 PM EDT.
There are no upcoming dividends for Cognition Therapeutics.
Cognition Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Cognition Therapeutics.
Cognition Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.